Overview

Voriconazole (Vfend) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
To collect the efficacy and safety informations of voriconazole related to their appropriate use in daily practice.
Details
Lead Sponsor:
Pfizer
Treatments:
Voriconazole